Moreover, we observed that chemotherapeutical agents combined with NOTCH1 inhibitor synergistically attenuate chemotherapy-enriched CSC population in vitro and in vivo. These data provide the possibility to efficiently eliminate bulk cell populations and cancer stem-like cells in HNSCC based on further understanding of CSCs and pharmacologic strategy targeting relevant molecular events. Here, NOTCH1 is linked to cancer.